1. Hypothalamic Rax+ tanycytes contribute to tissue repair and tumorigenesis upon oncogene activation in mice
    Wenhui Mu et al, 2021, Nature Communications CrossRef
  2. Recent advances in the molecular prognostication of meningiomas
    Elaina J. Wang et al, 2023, Frontiers in Oncology CrossRef
  3. High Grade Meningiomas: Current Therapy Based on Tumor Biology
    Juan Esteban Garcia-Robledo et al, 2022, Brain Tumors CrossRef
  4. Molecular characteristics of meningiomas
    Young Suk Lee et al, 2020, Journal of Pathology and Translational Medicine CrossRef
  5. The Genomic Landscape of Meningiomas
    Amy Y. Zhao et al, 2020, Meningiomas CrossRef
  6. A novel BRAF::PTPRN2 fusion in meningioma: a case report
    Nishanth S. Sadagopan et al, 2023, Acta Neuropathologica Communications CrossRef
  7. Genetic landscape of meningioma
    Sayaka Yuzawa et al, 2016, Brain Tumor Pathology CrossRef
  8. Optimizing gDNA extraction from fresh frozen meningioma tissue for downstream genetic analysis
    D.T. Proctor et al, 2017, Clinical Biochemistry CrossRef
  9. Oncogenic PI3K mutations are as common asAKT1andSMOmutations in meningioma
    Malak Abedalthagafi et al, 2016, Neuro-Oncology CrossRef
  10. PIK3CA mutations in meningioma
    Gelareh Zadeh et al, 2016, Neuro-Oncology CrossRef
  11. Benign Neoplasms of the Nasal Cavity, Paranasal Sinuses, and Nasopharynx
    Lester D.R. Thompson, 2019, Head and Neck Pathology CrossRef
  12. Molecular genetics of meningiomas
    Mark W. Youngblood et al, 2020, Meningiomas, Part I CrossRef
  13. Proteomic analysis of meningiomas reveals clinically distinct molecular patterns
    Michail-Dimitrios Papaioannou et al, 2019, Neuro-Oncology CrossRef
  14. Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One WithBRAFV600EMutation and Clinical Response to theBRAFInhibitor Dabrafenib
    Aisulu Usubalieva et al, 2015, Journal of Neuropathology & Experimental Neurology CrossRef
  15. Linear Accelerator–Based Radiosurgery of Grade I Intracranial Meningiomas
    Sara Alatriste-Martínez et al, 2019, World Neurosurgery: X CrossRef
  16. Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma
    Dustin T Proctor et al, 2019, OncoImmunology CrossRef
  17. Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms
    Dustin T. Proctor et al, 2018, World Neurosurgery CrossRef
  18. Molecular classification and grading of meningioma
    MacLean P. Nasrallah et al, 2023, Journal of Neuro-Oncology CrossRef
  19. Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies
    Ahmad A. Nazem et al, 2020, Oncotarget CrossRef
  20. Liquid biopsy evaluation of circulating tumor DNA, miRNAs, and cytokines in meningioma patients
    Veronica Aran et al, 2024, Frontiers in Neurology CrossRef
  21. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing
    Zsolt Zador et al, 2018, PLOS ONE CrossRef